German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer.

von Minckwitz, Gunter

German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct 2013 - 3531-9 p. digital

Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1527-7755

10.1200/JCO.2012.47.2167 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Breast Neoplasms--drug therapy
Capecitabine
Carcinoma, Ductal, Breast--drug therapy
Carcinoma, Lobular--drug therapy
Chemotherapy, Adjuvant
Cyclophosphamide--administration & dosage
Deoxycytidine--administration & dosage
Diphosphonates--administration & dosage
Epirubicin--administration & dosage
Female
Fluorouracil--administration & dosage
Follow-Up Studies
Germany
Humans
Ibandronic Acid
Middle Aged
Neoplasm Grading
Neoplasm Staging
Paclitaxel--administration & dosage
Prognosis
Survival Rate
Young Adult